XLRN Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Acceleron Pharma Inc. and Encourages Investors to Contact the Firm

NEW YORK, July 6, 2020 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Acceleron Pharma Inc. ("Acceleron" or the "Company") (NASDAQ: XLRN). Investors who purchased Acceleron securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/xlrn. 

The investigation concerns whether Acceleron and its board of directors have breached fiduciary duties.

If you are aware of any facts relating to this investigation, or purchased Acceleron shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/xlrn.     You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484. 

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration.   Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | [email protected]

View original content to download multimedia:http://www.prnewswire.com/news-releases/xlrn-investor-alert-bronstein-gewirtz--grossman-llc-announces-investigation-of-acceleron-pharma-inc-and-encourages-investors-to-contact-the-firm-301088608.html

SOURCE Bronstein, Gewirtz & Grossman, LLC